Filtered By:
Management: Funding
This page shows you your search results in order of relevance. This is page number 20.
Order by Relevance | Date
Total 633 results found since Jan 2013.
MicroTransponder completes $3.4M in funding, gets key patent
Dallas-based MicroTransponder Inc., a privately-held medical device company, has completed a $3.39 million funding round this summer, which will enable the company to accelerate development of its wireless pain platform.
The funding will allow MicroTransponder to complete three additional clinical trials using its neurostimulation system to treat both stroke patients and tinnitus patients, Jordan Curnes, co-founder, president and chief operating officer, told me.
Tinnitus is the medical term for…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - August 30, 2013 Category: Pharmaceuticals Authors: Bill Hethcock Source Type: research
Binghamton University researcher awarded funding to help heart attack risk
(Binghamton University) Binghamton University researcher Amber Doiron, hopes to give doctors a more accurate way of determining a patient's risk of heart attack or stroke.
Source: EurekAlert! - Medicine and Health - September 10, 2013 Category: Global & Universal Source Type: news
As preschool obesity rates dip, Boston Children’s expert suggests feds step to the plate
The scales may not be tipping quite so precipitously for some low-income preschoolers. So says a new report from the Centers for Disease Control and Prevention (CDC). Nineteen states saw small decreases in obesity rates among preschoolers between 2008 and 2011, while rates held steady in another 20 states. Is this cause for celebration, cautious optimism or concern?
Perhaps all of the above, says David Ludwig, MD, PhD, director of the New Balance Foundation Obesity Prevention Center Boston Children’s Hospital. “The report is a small, but encouraging, sign after nearly half a century of bad news.” The latest data...
Source: Thrive, Children's Hospital Boston - September 11, 2013 Category: Pediatrics Authors: Lisa Fratt Tags: All posts Childhood obesity Children's in the news Health & wellness Healthful eating Research David Ludwig New Balance Foundation Obesity Prevention Center Source Type: news
President's Page: An Urgent Call to Action: Graduate Medical Education Funding and the Future of Health Care
Cardiovascular medicine is experiencing a confluence of events that pose a significant threat to the future health of the nation. By 2030, it is predicted that more than 40% of adult Americans will have some form of cardiovascular disease. In addition, current projections indicate a 25% increase in the prevalence of both heart failure and stroke over the next 20 years—a result of an aging U.S. population . To make matters more complicated, an additional 30 million Americans will be seeking healthcare services beginning as early as next year as a result of the Affordable Care Act .
Source: Journal of the American College of Cardiology - October 2, 2013 Category: Cardiology Authors: John Gordon Harold, Patrick T. O'Gara, Joseph A. Hill, Marvin A. Konstam Tags: FROM THE ACC Source Type: research
Sustaining A Coordinated, Regional Approach To Trauma And Emergency Care Is Critical To Patient Health Care Needs Overview
We describe the components of a regionalized trauma system, review the evidence in support of this approach, and discuss the challenges to sustaining systems that are accountable and affordable.
Source: Health Affairs - December 3, 2013 Category: Global & Universal Authors: Eastman, A. B., MacKenzie, E. J., Nathens, A. B. Tags: Access To Care, Health Reform, Hospitals, Insurance Coverage, Quality Of Care, Health Spending Overview Source Type: research
Tech titans gather to make winners of the 'Oscars of science' into instant millionaires
Silicon Valley hosts lavish ceremony for Breakthrough prize that aims to give scientists celebrity status and inspire interest in life's 'big questions'Silicon Valley has a tendency to tackle social ills with big ideas, its feisty startups revolutionising everything from healthcare to education. Now a handful of billionaire engineers have turned their attention to a social blight that affects their own kind: the lack of appreciation (and funding) for scientists.The second Breakthrough prize for life sciences is being awarded on Thursday at Nasa's Ames Research Centre in Mountain View, California, about a five-minute drive ...
Source: Guardian Unlimited Science - December 7, 2013 Category: Science Authors: Parmy Olson Tags: United States Culture World news Mark Zuckerberg Media Kevin Spacey Sergey Brin Technology Science prizes UK news Film California The Observer Glenn Close Source Type: news
Dementia research funding should be on same footing as cancer, says charity
This article was amended on Wednesday 11 December 2013. Alzheizmer's Research Trust is now called Alzheimer's Research UK. This has been corrected.DementiaMental healthMedical researchHaroon Siddiquetheguardian.com © 2013 Guardian News and Media Limited or its affiliated companies. All rights reserved. | Use of this content is subject to our Terms & Conditions | More Feeds
Source: Guardian Unlimited Science - December 11, 2013 Category: Science Authors: Haroon Siddique Tags: The Guardian Mental health News Medical research Society Dementia UK news Science Source Type: news
NIH and NFL tackle concussion research
(NIH/National Institute of Neurological Disorders and Stroke) The National Institutes of Health has selected eight projects to receive support to answer some of the most fundamental problems on traumatic brain injury, including understanding long-term effects of repeated head injuries and improving diagnosis of concussions. Funding is provided by the Sports and Health Research Program, a partnership among the NIH, the National Football League, and the Foundation for the National Institutes of Health.
Source: EurekAlert! - Social and Behavioral Science - December 16, 2013 Category: Global & Universal Source Type: news
Researchers ID more pesticides linked to Parkinson's, gene that increases risk
This report provides evidence for the relevance of ALDH inhibition in Parkinson's disease pathogenesis, identifies pesticides that should be avoided to reduce the risk of developing Parkinson's disease and suggests that therapies modulating ALDH enzyme activity or otherwise eliminating toxic aldehydes should be developed and tested to potentially reduce Parkinson's disease occurrence or slow its progression, particularly for patients exposed to pesticides," the study states.
The study was funded in part by the National Institute of Environmental Health Sciences (P01ES016732, R01ES010544, 5R21ES16446-2 and U54ES0120...
Source: UCLA Newsroom: Health Sciences - February 3, 2014 Category: Universities & Medical Training Source Type: news
Alignment of United States funding for cardiovascular disease research with deaths, years of life lost, and hospitalizations
Cardiovascular diseases, including ischemic heart disease and stroke, are the leading cause of death in the United States . Since 2009, public funding for cardiovascular research has exceeded $2billion annually ; however, the extent to which this aligns with national health metrics and compares with other conditions is unknown. Determining the alignment between disease burden and research investment could promote greater transparency in funding allocation and aid in setting national research priorities .
Source: International Journal of Cardiology - January 21, 2014 Category: Cardiology Authors: Chris Stockmann, Adam L. Hersh, Catherine M.T. Sherwin, Michael G. Spigarelli Tags: Online Letters to the Editor Source Type: research
Recent HIV/AIDS News from NIAID and NIH
February 25, 2014: NIH Expands Focus of Research Funding Opportunity Targeting HIV Reservoirs
“The National Institute of Allergy and Infectious Diseases (NIAID) and the National Institute of Mental Health, both part of the National Institutes of Health, recently expanded the scientific scope of an HIV-cure related funding announcement to allow for a broader range of studies and approaches.
“Specifically, the funding opportunity 'Targeting Persistent HIV Reservoirs,' which was originally issued February 17, 2012, has been significantly expanded to allow for 'proposed basic research into the cellular an...
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - February 28, 2014 Category: Infectious Diseases Source Type: news
Amy Comstock Rick - PARKINSONS
By far, the greatest challenge facing the Parkinson’s community today is the lack of disease modifying therapies to slow or stop the progression of the disease.
Parkinson’s disease is one of the most complicated diseases we know of. No two people with Parkinson’s have the same symptoms, and there is no one-size-fits-all approach to treating the disease. People affected are often forced to stop working and manage their disease full time. If Parkinson’s itself isn’t disrupting enough, often the medications used to treat the disease cause a host of side effects that impact the quality of life and sometimes stop bein...
Source: PHRMA - March 27, 2014 Category: Pharmaceuticals Authors: Julie Source Type: news
Todd Sherer
CEOTodd Sherer, PhD, is the Chief Executive Officer of The Michael J. Fox Foundation for Parkinson's Research (MJFF), reporting to the Board of Directors. Formally trained as a neuroscientist, he directs the organization's research strategy and is responsible for the organization's overall scientific and fundraising direction to speed treatment breakthroughs and a cure for Parkinson's disease.
Dr. Sherer has been a key architect of the Foundation's strategy to define high-priority research areas for Parkinson's disease - therapeutic targets and approaches that are closest or most critical to practical relevance in patients...
Source: PHRMA - March 31, 2014 Category: Pharmaceuticals Authors: Julie Source Type: news
UCLA scientists hunt down origin of Huntington's disease in the brain
The gene mutation that causes Huntington's disease appears in every cell in the body, yet it kills only two types of brain cells. Why? UCLA scientists used a unique approach to switch the gene off in individual brain regions and zero in on those that play a role in causing the disease in mice.
Published in the April 28 online edition of the journal Nature Medicine, the research sheds light on where Huntington's starts in the brain. It also suggests new targets and routes for therapeutic drugs to slow the devastating disease, which strikes an estimated 35,000 Americans.
"From Day One of conception, the mutant gene that caus...
Source: UCLA Newsroom: Health Sciences - April 28, 2014 Category: Universities & Medical Training Source Type: news
